PHARMACOKINETICS OF METOPROLOL IN PATIENTS WITH HEPATIC CIRRHOSIS

被引:58
作者
REGARDH, CG [1 ]
JORDO, L [1 ]
ERVIK, M [1 ]
LUNDBORG, P [1 ]
OLSSON, R [1 ]
RONN, O [1 ]
机构
[1] SAHLGRENS HOSP,DEPT 2,S-41345 GOTHENBURG,SWEDEN
关键词
D O I
10.2165/00003088-198106050-00004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:375 / 388
页数:14
相关论文
共 25 条
[1]  
ABLAD B, 1980, PHARM ANTIHYPERTENSI, P247
[2]  
BENGTSSON C, 1975, CLIN PHARMACOL THER, V17, P400
[3]  
BORG KO, 1975, ACTA PHARMACOL TOX, V36, P125
[4]   STUDY OF FACTORS INFLUENCING DRUG DISPOSITION IN CHRONIC LIVER-DISEASE, USING MODEL DRUG (+)-PROPRANOLOL [J].
BRANCH, RA ;
JAMES, J ;
READ, AE .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (02) :243-249
[5]  
ERVIK M, 1981, BIOMEDICAL MASS SPEC
[6]  
GIBALDI M, 1975, PHARMACOKINETICS
[7]   THE EFFECT OF IMPAIRED RENAL-FUNCTION ON THE PLASMA-CONCENTRATION AND URINARY-EXCRETION OF METOPROLOL METABOLITES [J].
HOFFMANN, KJ ;
REGARDH, CG ;
AURELL, M ;
ERVIK, M ;
JORDO, L .
CLINICAL PHARMACOKINETICS, 1980, 5 (02) :181-191
[8]   DECREASED 1ST-PASS METABOLISM OF LABETALOL IN CHRONIC LIVER-DISEASE [J].
HOMEIDA, M ;
JACKSON, L ;
ROBERTS, CJC .
BRITISH MEDICAL JOURNAL, 1978, 2 (6144) :1048-1050
[9]   EFFECT OF SPIRONOLACTONE ON ANTIPYRINE METABOLISM IN MAN [J].
HUFFMAN, DH ;
SHOEMAN, DW ;
PENTIKAINEN, P ;
AZARNOFF, DL .
PHARMACOLOGY, 1973, 10 (06) :338-344
[10]  
JOHNSSON G, 1975, ACTA PHARMACOL TOX, V36, P31